Plasma alarmin S100A8/A9 serves as a potential biomarker of major adverse cardiovascular events after acute myocardial infarction
@article{CDT152900,
author = {Jingjiang Pi and Liang Geng and Chenghui Fan and Jing Xu and Xingxu Wang and Qi Zhang and Wei Wei},
title = {Plasma alarmin S100A8/A9 serves as a potential biomarker of major adverse cardiovascular events after acute myocardial infarction},
journal = {Cardiovascular Diagnosis and Therapy},
volume = {16},
number = {3},
year = {2026},
keywords = {},
abstract = {},
issn = {2223-3660}, url = {https://cdt.amegroups.org/article/view/152900}
}